FOXP1 and acute myeloid leukemia: In AML (Figure 1B), the data are less conclusive, and much remains to be clarified, but there is evidence that FOXP1 regulates the expression of SIRT1, which correlates with a greater resistance of AML cells to drugs such as daunorubicin.